Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Oct;11(5):357-365.
doi: 10.1007/s12265-018-9807-z. Epub 2018 May 9.

Regenerative Therapy for Cardiomyopathies

Zi Wang  1 , Xuan Su  1 , Muhammad Ashraf  2 , Il-Man Kim  2 , Neal L Weintraub  2 , Meng Jiang  3 , Yaoliang Tang  4
Affiliations
Review

Regenerative Therapy for Cardiomyopathies

Zi Wang et al. J Cardiovasc Transl Res. 2018 Oct.

Abstract

Despite substantial advances in the development of medical and interventional strategies in ischemic and non-ischemic heart diseases, cardiovascular diseases (CVDs) remain the leading cause of mortality and morbidity worldwide. Stem cell therapy for heart disease has gained traction over the past two decades and is an emerging option for the treatment of myocardial dysfunction. In this review, we summarize the current literature on different types of stem cells and their potential usage in ischemic and non-ischemic heart diseases. We emphasize the clinical utility of stem cells to improve myocardial structural and function, promote microvascular angiogenesis, and diminish scar size and major adverse cardiovascular events. We also discuss the therapeutic potential of microvesicles, such as exosomes, in the treatment of CVDs, which may open novel avenues for further clinical studies.

Keywords: Angiogenesis; Exosomes; Ischemic heart diseases; Microvesicles; Non-ischemic heart diseases; Stem cells.

PubMed Disclaimer

References

    1. Sun R, Li X, Liu M, Zeng Y, Chen S, Zhang P. Advances in stem cell therapy for cardiovascular disease (Review) International journal of molecular medicine. 2016;38(1):23–9. - PMC - PubMed
    1. Trindade F, Leite-Moreira A, Ferreira-Martins J, Ferreira R, Falcao-Pires I, Vitorino R. Towards the standardization of stem cell therapy studies for ischemic heart diseases: Bridging the gap between animal models and the clinical setting. International journal of cardiology. 2017;228:465–80. - PubMed
    1. Bernstein HS, Srivastava D. Stem cell therapy for cardiac disease. Pediatric research. 2012;71(4 Pt 2):491–9. - PubMed
    1. Moreira ML, da Costa Medeiros P, de Souza SA, Gutfilen B, Rosado-de-Castro PH. In Vivo Tracking of Cell Therapies for Cardiac Diseases with Nuclear Medicine. Stem cells international. 2016;2016:3140120. - PMC - PubMed
    1. Silva GV, Litovsky S, Assad JA, Sousa AL, Martin BJ, Vela D, et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation. 2005;111(2):150–6. - PubMed

Publication types